Resources Contact Us Home
Antibodies specific for soluble amyloid beta peptide protofibrils and uses thereof

Image Number 14 for United States Patent #8106164.

The invention pertains to the development of antibodies that specifically bind amyloid beta protein (Abeta) in its protofibril conformation. The invention also comprises methods of using anti-Abeta protofibril antibodies to diagnose or treat Alzheimer's disease, Down's syndrome Lewybody dementia, vascular dementia, and other neurodegenerative disorders. Furthermore, the invention pertains to the use of anti-Abeta protofibril antibodies to screen and identify substances that will modulate protofibril activity or formation in vitro or in vivo. The invention also pertains to methods for synthesising pure Abeta protofibril antigens as well as to a method for stabilising Abeta protofibrils antigens as well as to a method for stabilising Abeta protofibrils.

  Recently Added Patents
Data transfer device and data transfer method
Methods and arrangements for realising betting with off-line terminal
Combination for composite layered chip package
Adhering composition and method of applying the same
Optical article comprising a temporary anti-fogging coating with improved durability
Profiled rail for advertising/display units
  Randomly Featured Patents
Apparatus for applying tape with fastener profiles to a web
Method and system for inferring intake manifold pressure of a variable compression ratio engine
Determination of analytes in biological fluids in the presence of substances interfering with assays therefor
TOF mass spectrometry with correction for trajectory error
Control system and strategies for a double acting secondary sheave servo for a continuously variable transmission
Internally delaminating tabbed innerseal for a container and method of applying
Picture display apparatus
Method of changing strip material on a manufacturing machine
Cloth reserve dyeing
Process for derivatizing polyglucosamines